Clinical trial
Creatine as a New Therapeutic Strategy in Depression
NCT00313417 · Herzog Hospital, Other · Terminated
Key facts
| NCT number | NCT00313417 |
|---|---|
| Title | Creatine as a New Therapeutic Strategy in Depression |
| Official title | A Double-blind, Parallel, Randomized, add-on Clinical Trial of Creatine Versus Placebo Added to Antidepressant Treatment of Patients With Major Depressive Episode. |
| Lead sponsor | Herzog Hospital, Other |
| Collaborators | Beersheva Mental Health Center |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Dietary Supplement, Other |
| Interventions | Creatine monohydrate, Placebo |
| Enrollment | 18 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Apr 12, 2006 |
| Last update posted | Apr 5, 2013 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: